Health-related quality of life in patients with primary Sjögren's syndrome and xerostomia: A comparative study

Gerodontology

Volumn 19, Issue 1, 2002, Pages 53-59

  Rostron, Jocelyne ^a   Rogers, Simon ^a   Longman, Lesley ^a   Kaney, Sue ^a   Field, E Anne ^a  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ATTITUDE TO HEALTH; COMPARATIVE STUDY; CONFIDENCE INTERVAL; DAILY LIFE ACTIVITY; FEMALE; HEALTH STATUS; HUMAN; MALE; MIDDLE AGED; NONPARAMETRIC TEST; PATHOPHYSIOLOGY; PHYSIOLOGY; PSYCHOLOGY; QUALITY OF LIFE; SALIVA; SECRETION (PROCESS); SECRETION RATE; SJOEGREN SYNDROME; STATISTICAL ANALYSIS; STATISTICS; VERY ELDERLY; XEROSTOMIA; ARTICLE; PSYCHOLOGICAL ASPECT; SECRETION;

ACTIVITIES OF DAILY LIVING; ADULT; AGED; AGED, 80 AND OVER; ATTITUDE TO HEALTH; CONFIDENCE INTERVALS; FEMALE; HEALTH STATUS; HUMANS; MALE; MATCHED-PAIR ANALYSIS; MIDDLE AGED; QUALITY OF LIFE; SALIVA; SECRETORY RATE; SJOGREN'S SYNDROME; STATISTICS AS TOPIC; STATISTICS, NONPARAMETRIC; XEROSTOMIA; STATISTICS;

EID: 0036654504     PISSN: 07340664     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1741-2358.2002.00053.x     Document Type: Article

References (30)

1. 1 Sjögren H. Auf Kenntnis der Keratoconjunctivitis sicca (Keratitis filifomiis bei Hypofunction der Tranendrusen). Acta Opthalmologica 1933 ; 1 (suppl 2): 1–151.
2. 2 Whaley K, Williamson J, Wilson T, et al. Sjögren's syndrome and autoimmunity in a geriatric population. Age Ageing 1972 ; 1: 197–206.
3. 3 Sreebny LM, Valdini A. Xetostomia. Part I: Relationship to other oral symptoms and salivary gland hyptofunction. Oral Surg Oral Med Oral Pathol 1988 ; 66: 451–458.
4. 4 Provost T T. The Skin and Sjögren's Syndrome In: The New Sjögren's Syndrome Handbook, eds. Carsons S, Harris E K. Oxford, 1998.
5. 5 Rose R M. Ear, Nose and Throat Problems. In: The New Sjögren's Syndrome Handbook, eds. Carsons S, Harris F K. Oxford, 1998.
6. 6 Willems J J, Nachtigall. Gynaecological issues in with Sjögren's Syndrome. In: The New Sjögren's Syndrome Handbook, eds. Carsons S, Harris E K. Oxford, 1998.
7. 7 Barendrecgt P J, Visser M R M, Smets E M A, et al. Fatigue in primary Sjögren's syndrome. Ann Rheum Dis 1998 ; 57: 291–295.
8. 8 Strombeck B, Ekdahl C, Manthorpe R, et al. Health‐related quality of life in Primary Sjögren's syndrome, rheumatoid arthritis and fibromyalgia compared to normal population using SF‐36. Scand J Rheumatol 2000 ; 29: 20–28.
9. 9 Valtysdottir S T, Gudbjornsson B, Lindqvist U, et al. Anxiety and depression in patients with primary Sjögren's syndrome, J Rheumatol: 1998 ; 27: 165–169.
10. 10 Bjordal K. Quality of life in patients treated for head and neck cancer: methodological and clinical issues. Norwegian Cancer Society and the Norwegian Radium Hospital, Department of Medical Oncology and Radiotherapy, University of Oslo, Norway, 1996.
11. 11 Garrat A M, Macdonald L M, Ruta D A, et al. Towards measurement of outcome for patients with varicose veins. Quality in Health Care 1993 ; 2: 5–10.
12. 12 Whalley D, McKenna S P, De, Jong Z, et al. Quality of Life in Rheumatoid arthritis. Br J Rheumatol 1997 ; 36: 884–888.
13. 13 Rogers S N, Humphris G, Lowe D, et al. The impact of surgery for oral cancer on quality of life as measured by the Medical Outcomes Short Form 36. Oral Oncology, 1998 ; 34: 171–179.
14. 14 Tarlov A R, Ware J E, Greenfield S, et al. The Medical Outcomes Study: an application of methods for monitoring the results of medical care. J Am Med Assoc 1989 ; 262: 925–930.
15. 15 Ware J E, Sherbourne C. The MOS 36 item short‐form health survey 1: conceptual framework and item selection. Med Care 1992 ; 30: 473–483.
16. 16 Ware J E. Measuring patients' views: the optitnum outcome measure. SF‐36: a valid, reliable assessment of health from the patients' point of view. Br Med J 1993 ; 306: 1429–1430.
17. 17 Garrat A M, Ruta D A, Abdalla M I, et al. The SF‐36 Health Survey Questionnaire: an outcome measure suitable for routine use within the NHS Br Med J 1993 ; 306: 1440–1444.
18. 18 Thomas E, Hay E M, Hajeer A, et al. Sjögren's syndrome: a community ‐ based study of prevalence and impact. Br J Rheumatol 1998 ; 37: 1069–1076.
19. 19 Bowman S J, Hamburger J, Ainsworth J, et al. The health status and health resource utilization by patients with Primary Sjögren's syndrome. Arthritis Rheum 2000 ; 43: 303.
20. 20 Vitali C, Bombardieri S. The European classification criteria for Sjögren's syndrome. Proposal for a modification of the rules for classification suggested by the analysis of the receiver operating characteristic curve of the criteria performance. J Rheumatol 1997 ; 24: 38.
21. 21 Vitali C, Bombardieri S, Moutsopoulos H M, et al. Preliminary criteria for the classification of Sjögren's syndrome: Results of a prospective concerted action supported by the European Community. Arthritis Rheum 1993 ; 36: 340–347.
22. 22 Sreebny L M, Valdini A. Xerostomia: a neglected symptom. Arch Intern Med 1987 ; 47: 1333–1337.
23. 23 Brazier J E, Harper R, Jones N M B, et al. Validating the SF ‐ 36 health survey questionnaire: a new measure for primary care. Br Med J 1993 ; 305: 160–164.
24. 24 Jenkinson C, Coulter A, Wright L. Short Form 36 (SF‐36) health survey questionnaire. Normative data for adults of working age. Br Med J 1993 ; 306: 1437–1440.
25. 25 Anderson R T, Aaronson N K, Wilkin D. Critical review of international assessments of health‐related quality of life. Quality of Life Research 1993, 2: 369–395.
26. 26 Thomson W M, Chalmers J M, Spencer A J, et al. The Xerostomia Inventory: a multi‐item approach to measuring dry mouth. Community Dent Health 1999 ; 16: 12–17.
27. 27 Allen P F, McMillan A S, Walshaw D, et al. A comparison of the validity of generic and disease specific measures in the assessment of oral health‐related quality of life. Community Dent Oral Epidemiol 1999 ; 27: 344–352.
28. 28 Levine R S. Xerostomia ‐ aetiology and management. Dent Update 1989: 12–15.
29. 29 Navazesh M, Christensen C, Brightman V. Clinical criteria for the diagnosis of salivary gland hypofunction. J Dent Res 1992 ; 71: 1363–1369.
30. 30 Bell M, Askari A, Bookman A, et al. Sjögren's syndrome: a critical review of clinical management. J Rheumatol 1999 ; 26: 2051–2061.